Peripheral blood-derived hematopoietic stem cells for treatment of systemic mastocytosis
The aim of this study is to assess whether transplantation of peripheral blood-derived hematopoietic stem cells (PB-HSCs) can effectively treat systemic mastocytosis.
Read More
No additional information regarding the therapeutic cells was provided by the sponsor.
Read More
Product Information for
Peripheral blood-derived hematopoietic stem cells for treatment of systemic mastocytosis